PA
ALGN icon

PharVision Advisers’s Align Technology ALGN Stock Holding History

PharVision Advisers’s Portfolio ALGN Stock Details ALGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,677
Closed -$210K – 681
2025
Q3 		$210K Buy
+1,677
New +$263K 0.12% 478
2025
Q2 		– Sell
-1,347
Closed -$214K – 271
2025
Q1 		$214K Buy
1,347
+259
+24% +$50.8K 0.3% 184
2024
Q4 		$227K Buy
+1,088
New +$243K 0.19% 252

Other funds holding ALGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PharVision Advisers's ALGN Position: Q4 2025 in Review

PharVision Advisers sold out of Align Technology (ALGN) in Q4 2025, closing a stake of 1,677 shares — an estimated $210K sold.

PharVision Advisers first reported a position in ALGN in Q4 2024 and held it in 3 quarters. The position peaked at $227K in Q4 2024. 666 funds tracked by Wall St. Rank hold ALGN as of Q4 2025.

  • PharVision Advisers reported no remaining Align Technology position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 1,677 Align Technology shares in Q4 2025, an estimated $210K.
  • PharVision Advisers first reported a position in Align Technology in Q4 2024 and held it in 3 quarters.
  • PharVision Advisers's Align Technology position peaked at $227K in Q4 2024.
  • 666 funds tracked by Wall St. Rank held Align Technology as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.